Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY: XLV )

144.03 +1.15 (+0.80%)
Official Closing Price Updated: 8:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
The Next Big Wave Of Ai Could Be In Healthcare
Artificial intelligence could boost pharma profits by $250 billion. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq 100 Eyes Record High Close, Fifth Positive Week As Traders Flock To AI-Linked Stocks: What's Driving Markets Friday?
Technology stocks surged on Friday, rebounding sharply after Thursday’s decline, as investor confidence in the artificial intelligence-driven rally remained high. 
Via Benzinga
Bonds Break Down And Send Everyone To Cash
This situation is where the danger, the opportunity, and the action are right now. 
Via Talk Markets
Large Cap Biopharmaceuticals Performance
The biotech sector remains a laggard YTD as can be seen by the IBB​​​​​​​. 
Via Talk Markets
Healthcare And Biotech Investing 101: What You Need To Know.
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mind Those “Defensive” Equities
In the first quarter of 2024, Canadian business insolvencies climbed 87.2% higher than the same quarter last year. 
Via Talk Markets
Hims & Hers Health Stock Could Become a Wealth Compounder
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 
Via MarketBeat
Topics Economy
Exposures Economy
3 Biotech Stocks to Double Your Money in the Next 24 Months
The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates. 
Via InvestorPlace
Shocker Of 2024: Utilities Overtake Tech Sector — 10 Stocks Behind The Shift
Utilities, once the underperformers, have emerged as the surprise winners in S&P 500's first four months. Tech dipped while utilities surged. 
Via Benzinga
Topics Stocks
Exposures US Equities
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
Via Talk Markets
Topics ETFs
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year. 
Via MarketBeat
3 Biotech Stocks Set to Double by 2028
These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains. 
Via InvestorPlace
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. and key allies explore further sanctions against Tehran. 
Via Benzinga
Tesla Cuts 15k Jobs As EVs Fall Out Of Favor
Since lower prices amid growing competition and waning demand aren’t spurring sales, Tesla announced it would cut 15,000 jobs or about 10% of its staff on Monday. 
Via Talk Markets
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets
Stocks Stay Afloat On Strong Retail Sales, Middle East Relief; Bonds Drop: What's Driving Markets Monday?
Wall Street can breathe a sigh of relief following the tense events on Saturday night, when Iran launched airstrikes against Israel. 
Via Benzinga
Citi’s Results Say This About The Stock Market
Investors now have an inside look at what one of Wall Street's biggest names is doing with its money. Corporations and clients all see new highs in stocks 
Via MarketBeat
Topics Economy
Exposures Interest Rates
4 Sector ETFs & Stocks To Benefit From Hot Inflation
U.S. inflation jumped in March, surpassing expectations primarily due to higher petrol and shelter costs, dashing hopes of a June interest rate cut by the Fed. 
Via Talk Markets
Topics ETFs Economy Energy
Exposures Fossil Fuels Interest Rates
Real Estate, Regional Bank Stocks Tank, Energy Cushions The Blow: March Inflation Rates Shake Up Sectors
Inflation unexpectedly surges, shattering hopes for Fed rate cuts & sending stocks down. Core inflation also exceeded expectations. No sector escapes losses, with real estate hit hardest. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Stocks Fall Ahead Of Key Inflation Data, Gold Defends Record Highs; Bitcoin Stumbles Below $70,000: What's Driving Markets Tuesday?
Stocks edged lower during midday trading on Tuesday as traders maintained a cautious stance in anticipation of the highly awaited Consumer Price Index (CPI) report scheduled for Wednesday, which could... 
Via Benzinga
Topics Economy
Exposures Interest Rates
3 High Dividend Socks to Replace Lower Savings Yields Ahead
Three stocks stand out as the most attractive dividend propositions, particularly now that savings yields may drop as a result of the Fed's rate cuts 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Stocks Falter Ahead Of Data-Rich Week, Tesla Rallies On 'Robotaxi' Push, Bitcoin Reclaims $71,500: What's Driving Markets Monday?
It’s a lackluster trading session on Wall Street, with the main indices experiencing slight declines as traders adopt a cautious stance ahead of a data-heavy week. 
Via Benzinga
S&P 500, Nasdaq 100 Eye Record Close As Magnificent 7 Rally, Bitcoin Rebounds: What's Driving Markets Thursday?
US equities rallied on Thursday as investors expected slower labor market growth and potential rate cuts. AI-related stocks and major indices all saw gains. 
Via Benzinga
Topics Stocks
Exposures US Equities
Healthcare And Biotech Stocks Review: Q1 2024 Performance
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight... 
Via Talk Markets
Topics Stocks
Exposures US Equities
EXCLUSIVE: Pharma's Cloud Revolution — A $60B Market By 2030 With 1 Stock To Watch
DiMarzio, VP & Portfolio Manager at Rockland Trust, highlights healthcare sector's potential for rebound & growth opportunities for investors. 
Via Benzinga
Tuesday Talk: Big-Tech Under Attack
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs. 
Via Talk Markets
What Is An ETF For Dummies? Unlocking Strategic Insights
Via Talk Markets
Topics ETFs
Biotechnology And Healthcare, A Bit Of A Lull
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.